Laboratory Techniques in Thrombosis — a Manual
Editat de J. Jespersen, R.M. Bertina, F. Haverkateen Limba Engleză Paperback – 30 iun 2000
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1387.86 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 30 iun 2000 | 1387.86 lei 6-8 săpt. | |
Hardback (1) | 1313.87 lei 17-24 zile | +111.33 lei 6-12 zile |
SPRINGER NETHERLANDS – 31 dec 1998 | 1313.87 lei 17-24 zile | +111.33 lei 6-12 zile |
Preț: 1387.86 lei
Preț vechi: 1460.91 lei
-5% Nou
Puncte Express: 2082
Preț estimativ în valută:
265.73€ • 276.71$ • 220.48£
265.73€ • 276.71$ • 220.48£
Carte tipărită la comandă
Livrare economică 14-28 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792364726
ISBN-10: 0792364724
Pagini: 308
Ilustrații: XVIII, 308 p. 2 illus.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.47 kg
Ediția:2nd rev. ed. 1999
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 0792364724
Pagini: 308
Ilustrații: XVIII, 308 p. 2 illus.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.47 kg
Ediția:2nd rev. ed. 1999
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
1 Introduction to laboratory assays in haemostasis and thrombosis.- 2 Good medical laboratory services — guidelines.- 3 Blood collection and sample preparation: pre-analytical variation.- 4 Quality assessment of haemostatic assays and external quality assessment schemes.- 5 Activated partial thromboplastin time (APTT).- 6 Prothrombin time (PT).- 7 Endogenous thrombin potential.- 8 Fibrinogen.- 9 Activated factor VII.- 10 Factor VII activity and antigen.- 11 Factor VIII clotting activity.- 12 Von Willebrand factor.- 13 Antithrombin activity and antigen.- 14 Protein C activity and antigen.- 15 Protein S antigen.- 16 Protein S activity.- 17 Activated protein C (APC) resistance.- 18 Tissue factor pathway inhibitor (TFPI).- 19 Lupus anticoagulant.- 20 Heparin cofactor II.- 21 Fibrinopeptide A (FPA).- 22 Thrombin-antithrombin (TAT) complexes.- 23 Prothrombin fragment F1+2.- 24 Tissue-type plasminogen activator (t-PA) activity.- 25 Tissue-type plasminogen activator antigen (t-PA Ag).- 26 Plasminogen activator inhibitor-1 (PAI-1) antigen.- "10.1007/978-94-011-4722-4_27".- 28 Plasmin inhibitor activity (previously ?2-antiplasmin).- 29 Plasmin-?2-antiplasmin complexes (plasmin-plasmin inhibitor complexes).- 30 Soluble fibrin and degradation products of fibrinogen (FgDP), fibrin (FbDP; D-dimer) and total of FgDP and FbDP (TDP).- 31 Venous occlusion test in fibrinolysis assays.- 32 List of manufacturers.
Recenzii
`The objective towards standardization is largely met, since world experts on each assay collaborated to evaluate and compare the available methodologies and point to the advantages and disadvantages of each one. This book is written for clinical thrombosis and hemostasis laboratorians. Another attractive feature is the degree of expertise recruited to produce these critical summaries of existing methodologies. This book is a long overdue update of the first edition in view of the multitude of newly developed methodologies and the number of manufacturers involved.'
Demetra D. Callas, Loyola University Medical Center in Doody Publishing Inc.
Demetra D. Callas, Loyola University Medical Center in Doody Publishing Inc.